BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 6084700)

  • 1. Luminescence immunoassays: problems and possibilities.
    Wood WG
    J Clin Chem Clin Biochem; 1984 Dec; 22(12):905-18. PubMed ID: 6084700
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Commercially available luminometers and imaging devices for low-light level measurements and kits and reagents utilizing bioluminescence or chemiluminescence: survey update 4.
    Stanley PE
    J Biolumin Chemilumin; 1996; 11(4-5):175-91. PubMed ID: 8910141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Commercially available luminometers and imaging devices for low-light level measurements and kits and reagents utilizing bioluminescence or chemiluminescence: survey update 3.
    Stanley PE
    J Biolumin Chemilumin; 1994; 9(3):123-5. PubMed ID: 7942115
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and evaluation of luminescent tracers and hapten-protein conjugates for use in luminescence immunoassays with immobilised antibodies and antigens. A critical study of macro solid phases for use in immunoassay systems, Part II.
    Gadow A; Fricke H; Strasburger CJ; Wood WG
    J Clin Chem Clin Biochem; 1984 May; 22(5):337-47. PubMed ID: 6470624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Commercially available luminometers and imaging devices for low-light level measurements and kits and reagents utilizing bioluminescence or chemiluminescence: survey update 2.
    Stanley PE
    J Biolumin Chemilumin; 1994; 9(2):51-3. PubMed ID: 8023702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent progress in bioluminescence and chemiluminescence.
    Kricka JL; Thorpe GH
    Ann Biol Clin (Paris); 1985; 43(4):457-62. PubMed ID: 4091309
    [No Abstract]   [Full Text] [Related]  

  • 7. A survey of some commercially available kits and reagents which include bioluminescence or chemiluminescence for their operation: including immunoassays, hybridization, labels, probes, blots and ATP-based rapid microbiology. Products from more than forty companies.
    Stanley PE
    J Biolumin Chemilumin; 1993; 8(2):51-63. PubMed ID: 8456582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bioluminescence and chemiluminescence literature--immunoassays and protein blotting assays.
    Nozaki O; Kricka LJ; Stanley PE
    J Biolumin Chemilumin; 1992 Oct; 7(4):263-98. PubMed ID: 1442177
    [No Abstract]   [Full Text] [Related]  

  • 9. Bibliography. Luminescence literature. Chemiluminescent and bioluminescent immunoassays.
    Kricka LJ
    Luminescence; 2002; 17(5):343-53. PubMed ID: 12407673
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and properties of new luminescent acridinium-9-carboxylic acid derivatives and their application in luminescence immunoassays (LIA).
    Kinkel T; Lübbers H; Schmidt E; Molz P; Skrzipczyk HJ
    J Biolumin Chemilumin; 1989 Jul; 4(1):136-9. PubMed ID: 2801207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Commercially available luminometers and imaging devices for low-light measurements and kits and reagents utilizing bioluminescence or chemiluminescence: survey update I.
    Stanley PE
    J Biolumin Chemilumin; 1993; 8(5):237-40. PubMed ID: 8237467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemiluminescence: a new end-point for clinical assays.
    Bronstein I; Kricka LJ
    Clin Lab Manage Rev; 1990; 4(4):303-5. PubMed ID: 10105862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemiluminescence in immunoassays.
    Messeri G
    Am Clin Lab; 1998; 17(1):6-8. PubMed ID: 10177662
    [No Abstract]   [Full Text] [Related]  

  • 14. Routine luminescence immunoassays--dream or reality.
    Wood WG
    J Biolumin Chemilumin; 1989 Jul; 4(1):79-87. PubMed ID: 2801250
    [No Abstract]   [Full Text] [Related]  

  • 15. Magic Lite design and development.
    Woodhead JS; Weeks I
    J Biolumin Chemilumin; 1989 Jul; 4(1):611-4. PubMed ID: 2678929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assay drift in commercial immunoassay kits.
    Holding S; Heuck J
    Med Lab Sci; 1989 Oct; 46(4):378. PubMed ID: 2482401
    [No Abstract]   [Full Text] [Related]  

  • 17. An evaluation of four different luminescence immunoassay systems: CELIA (chemiluminescent immunoassay), SPALT (solid-phase antigen luminescence technique), ILMA (immunoluminometric assay) and ILSA (immunoluminometric labelled second antibody). A critical study of macro solid phases for use in immunoassay systems, Part III.
    Wood WG; Fricke H; Haritz J; Gadow A; Krausz HS; Tode B; Strasburger CJ; Scriba PC
    J Clin Chem Clin Biochem; 1984 May; 22(5):349-56. PubMed ID: 6432936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bibliography. Luminescence literature. Chemiluminescent and bioluminescent immunoassays.
    Luminescence; 2003; 18(5):283-300. PubMed ID: 14587081
    [No Abstract]   [Full Text] [Related]  

  • 19. Luminometer development in the last four decades: recollections of two entrepreneurs.
    Berthold F; Tarkkanen V
    Luminescence; 2013; 28(1):1-6. PubMed ID: 22949354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Initiation of luminol-based luminescence by injection of a single reagent, coupled with enhancement of light-output.
    Wood WG; Hantke U; Gross AJ
    J Clin Chem Clin Biochem; 1985 Jan; 23(1):47-9. PubMed ID: 3884728
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.